PACB
Pacific Biosciences Of California, Inc.
$1.53
+0.03 (+2.00%)
At close · Jul 15
Market Cap
$479.88M
Shares
310,601,688
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$160.01M
+3.9%
FY2025
Net Income
-$546.38M
-76.3%
FY2025
Gross Margin
28.61%
+4.4pp
FY2025
Operating Margin
-346.15%
-38.2pp
FY2025
Diluted EPS
-$1.82
-14.5%
FY2025
Operating Cash Flow
-$111.21M
+46%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 (G) | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 | FY2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $165M – $175M | $160.03M | $160.01M | $154.01M | $200.52M | $128.3M | $130.51M | $78.89M | $90.89M | $78.63M | $93.47M | $90.71M | $92.78M | $60.59M | $28.18M | $25.98M | $33.86M | $1.67M | $135K | |
| — | $100.04M | $114.23M | $116.73M | $147.74M | $79.27M | $71.65M | $46.33M | $56.32M | $53.53M | $58.81M | $46.55M | $39.33M | $37.19M | $21.76M | $25.04M | $20.83M | — | — | |
| — | $59.99M | $45.78M | $37.28M | $52.78M | $49.04M | $58.86M | $32.57M | $34.58M | $25.1M | $34.66M | $44.16M | $53.45M | $23.4M | $6.42M | $940K | $13.03M | $1.67M | $135K | |
| — | — | 28.61% | 24.21% | 26.32% | 38.22% | 45.1% | 41.28% | 38.04% | 31.92% | 37.08% | 48.68% | 57.61% | 38.62% | 22.78% | 3.62% | 38.49% | 100% | 100% | |
| — | $87.86M | $97.31M | $134.92M | $187.17M | $193M | $112.9M | $64.15M | $59.63M | $62.59M | $65.32M | $67.62M | $60.44M | $48.23M | $45.22M | $47.62M | $76.08M | $111.82M | $75.88M | |
| — | $132.48M | $141.49M | $175.02M | $169.82M | $160.85M | $124.12M | $72.8M | $75.49M | $63.49M | $59.12M | $47.79M | $45.19M | $38.03M | $38.75M | $47.66M | $46.71M | $30.09M | $12.33M | |
| — | — | $369.45M | $27.41M | $8.26M | $913K | $0 | $0 | $0 | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | — | — | $7.22M | $8.44M | $3.88M | $3.68M | $4.22M | $5.65M | $6.65M | $5.8M | $5.16M | $4.1M | |
| — | — | — | $12.82M | — | — | — | — | — | — | — | — | — | — | — | — | $4.94M | — | — | |
| — | $193.28M | $599.64M | $511.6M | $387.25M | $356.23M | $269.3M | $136.95M | $135.12M | $126.08M | $124.44M | $115.4M | $82.58M | $86.26M | $83.96M | $95.28M | $122.79M | $141.91M | $88.21M | |
| — | -$133.28M | -$553.86M | -$474.31M | -$334.47M | -$307.2M | -$210.44M | -$104.39M | -$100.55M | -$100.99M | -$89.78M | -$71.24M | -$29.13M | -$62.85M | -$77.54M | -$94.34M | -$109.76M | — | — | |
| — | — | -346.15% | -307.97% | -166.8% | -239.43% | -161.24% | -132.31% | -110.62% | -128.44% | -96.06% | -78.54% | -31.4% | -103.73% | -275.16% | -363.08% | -324.12% | — | — | |
| — | — | — | — | — | — | — | — | — | -$93.77M | -$81.34M | -$67.37M | -$25.46M | -$58.63M | -$71.9M | -$87.69M | -$103.95M | — | — | |
| — | $6.96M | $6.95M | $13.41M | $14.34M | $14.69M | $12.53M | $267K | $2.61M | $2.42M | $2.92M | $3.23M | $2.93M | $2.83M | $2.48M | $274K | $287K | — | — | |
| — | $12.47M | $14.76M | $23.78M | $32.68M | $7.64M | $93K | $2.06M | $1.02M | $848K | $516K | $103K | $364K | -$478K | $728K | $147K | $655K | $68K | $367K | |
| — | -$127.77M | -$546.06M | -$309.54M | -$318.16M | -$314.25M | -$274.87M | $29.4M | -$84.13M | — | — | — | — | — | — | — | — | — | — | |
| — | $804K | $318K | $316K | -$11.42M | $0 | -$93.65M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$128.58M | -$546.38M | -$309.85M | -$306.74M | -$314.25M | -$181.22M | $29.4M | -$84.13M | -$102.56M | -$92.19M | -$74.38M | -$31.7M | -$66.16M | -$79.29M | -$94.47M | -$109.39M | -$140.17M | -$87.7M | |
| — | — | -341.47% | -201.18% | -152.97% | -244.92% | -138.85% | 37.27% | -92.57% | -130.44% | -98.63% | -81.99% | -34.16% | -109.19% | -281.37% | -363.56% | -323.03% | -8373.12% | -64965.19% | |
| — | -$128.58M | -$546.38M | -$309.85M | -$306.74M | -$314.25M | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | -$129.1M | -$546.34M | -$309.65M | -$301.75M | -$317.93M | -$182.4M | $29.48M | -$84.09M | -$102.57M | -$92.23M | -$74.36M | -$31.71M | -$66.17M | -$79.31M | -$94.49M | -$109.31M | -$140.19M | — | |
| USD/shares | — | — | -$1.82 | -$1.13 | -$1.21 | -$1.40 | -$0.89 | $0.18 | -$0.55 | -$0.76 | — | — | — | — | — | — | — | — | — |
| USD/shares | — | — | -$1.82 | -$1.59 | -$1.21 | -$1.40 | -$0.89 | $0.17 | -$0.55 | -$0.76 | — | — | — | — | — | — | — | — | — |
| shares | — | — | 299.96M | 274.49M | 253.63M | 224.55M | 204.14M | 165.19M | 152.53M | 135.09M | 105.68M | 89.15M | 75.61M | 70.48M | 62.78M | 55.73M | 53.87M | 9938 | — |
| shares | — | — | 299.96M | 288.37M | 253.63M | 224.55M | 204.14M | 174.97M | 152.53M | 135.09M | 105.68M | 89.15M | 75.61M | 70.48M | 62.78M | 55.73M | 53.87M | 9938 | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative. (G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against the industry, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
—
Medical Devices median 2.22×
EV/EBIT
—
Medical Devices median 21.48×
P/E (TTM)
—
Medical Devices median 27.36×
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Reportable Segment | $160,005,000 | $154,014,000 | $200,521,000 | $128,304,000 |
By Geography (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Americas | $72,798,000 | $78,711,000 | $105,410,000 | $69,561,000 | — | — | — | — |
| United States | $69,700,000 | $75,300,000 | $100,500,000 | $66,800,000 | — | — | — | — |
| EMEA | $44,051,000 | $34,594,000 | $40,658,000 | $22,598,000 | — | — | — | — |
| Asia Pacific | $43,156,000 | $40,709,000 | $54,453,000 | $36,145,000 | $35,721,000 | $22,551,000 | $26,610,000 | $29,070,000 |
| Europe | — | — | $40,658,000 | $22,598,000 | $30,271,000 | $19,065,000 | $19,600,000 | $13,958,000 |
| North America | — | — | $105,410,000 | $69,561,000 | $64,521,000 | $37,277,000 | $44,681,000 | $35,598,000 |
By Product & Service (USD)
| Component | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|---|---|---|
| Product | $135,758,000 | $136,149,000 | $183,872,000 | $108,699,000 | $113,505,000 | $65,424,000 | $77,742,000 | $66,355,000 |
| Consumable | $81,939,000 | $70,373,000 | $63,421,000 | $59,980,000 | $52,181,000 | $31,142,000 | $32,616,000 | $37,863,000 |
| Instrument | $53,819,000 | $65,776,000 | $120,451,000 | $48,719,000 | $61,324,000 | $34,282,000 | $45,126,000 | $28,492,000 |
| Service and Other | $24,247,000 | $17,865,000 | $16,649,000 | $19,605,000 | $17,008,000 | $13,469,000 | $13,149,000 | $12,271,000 |